Two drugmakers win medication redemption lawsuit against goverment
Published: 2009-10-16 06:58:00
Updated: 2009-10-16 06:58:00
The Seoul Central District Court ruled on October 14 that Yungin Pharm and Ildong Pharm should not refund their revenues associated with bioequivalence fabrication cases, while 60 million won was fined to six local bioequivalence testing agencies.
The court ruled that these organizations parti...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
